Researchers say a widely used antifungal drug may hold promise for treating people with cystic fibrosis, a life-threatening genetic disorder.

The FDA has approved the first drug specifically designed to treat postpartum depression.

A new study in rodents has shown that the brain’s cerebellum also helps control the brain’s reward circuitry. Researchers found a direct neural connection from the cerebellum to the ventral tegmental area (VTA) of the brain

Vaccinations have begun in a phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis (TB) vaccine candidate.

African Americans who smoke appear to be at greater risk for peripheral artery disease, or PAD, new research has found.

Researchers have developed a simple blood test that can detect when a newly transplanted lung is being rejected by a patient, even when no outward signs of the rejection are evident.

Researchers have discovered how specific cells in the guts of mice slow down metabolism and eventually contribute to obesity, diabetes, hypertension and atherosclerosis. The findings, scientists say, could have important implications for the prevention and treatment of these kinds of metabolic diseases in humans.

A new study reveals that approximately 1 in 5 individuals may experience mental health symptoms up to 6 months after mild traumatic brain injury (mTBI), suggesting the importance of follow-up care for these patients.

Researchers have found that treating psoriasis, a chronic inflammatory skin disease, with biologic drugs that target immune system activity can reduce the early plaque buildup that clogs arteries, restricts blood flow and leads to heart attacks and stroke.

Hyperglycemia, or increased glucose, is common in patients with acute ischemic stroke and is associated with worse outcomes compared to normal glucose levels. Recent study results showed that intensive glucose management did not improve functional outcomes at 90 days after stroke.